Julie Milia

Université Fédérale de Toulouse Midi-Pyrénées — France

Medicine · Health Sciences

22h-index4.8kcitations68works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(56), RNA modifications and cancer(21), Lung Cancer Research Studies(15), Cancer, Lipids, and Metabolism(14), Cancer Immunotherapy and Biomarkers(11)

Publications68 total

EP.12.54 Real-World Use of Targeted Therapy Combinations to Manage Secondary Oncogenic Addiction in Non-Small Cell Cancer
Journal of Thoracic Oncology·2025
P3.03.34 Assessment of Minimal Residual Disease Using Liquid Biopsy in Patients With EGFR-Mutated Lung Cancer Treated With Osimertinib
Journal of Thoracic Oncology·2025
Abstract LB094: Assessment of minimal residual disease in lung cancer patients treated with osimertinib using liquid biopsy
Cancer Research·2024Open Access
Supplementary Figure S1 from RhoB Determines Tumor Aggressiveness in a Murine EGFR<sup>L858R</sup>-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer
2023Open Access
Supplementary Figure S4 from RhoB Determines Tumor Aggressiveness in a Murine EGFR<sup>L858R</sup>-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer
2023Open Access
Supplementary Figure S5 from RhoB Determines Tumor Aggressiveness in a Murine EGFR<sup>L858R</sup>-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer
2023Open Access
Data from RhoB Determines Tumor Aggressiveness in a Murine EGFR<sup>L858R</sup>-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer
2023Open Access
Legends to supplementary figures and tables from RhoB Determines Tumor Aggressiveness in a Murine EGFR<sup>L858R</sup>-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer
2023Open Access
Supplemental Methods from RhoB Determines Tumor Aggressiveness in a Murine EGFR<sup>L858R</sup>-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer
2023Open Access
Supplementary Figure S2 from RhoB Determines Tumor Aggressiveness in a Murine EGFR<sup>L858R</sup>-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer
2023Open Access
Data from RhoB Determines Tumor Aggressiveness in a Murine EGFR<sup>L858R</sup>-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer
2023Open Access
Supplemental Methods from RhoB Determines Tumor Aggressiveness in a Murine EGFR<sup>L858R</sup>-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer
2023Open Access
Supplementary Figure S5 from RhoB Determines Tumor Aggressiveness in a Murine EGFR<sup>L858R</sup>-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer
2023Open Access
Legends to supplementary figures and tables from RhoB Determines Tumor Aggressiveness in a Murine EGFR<sup>L858R</sup>-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer
2023Open Access
Supplementary Figure S3 from RhoB Determines Tumor Aggressiveness in a Murine EGFR<sup>L858R</sup>-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer
2023Open Access
Supplementary Table S2 from RhoB Determines Tumor Aggressiveness in a Murine EGFR<sup>L858R</sup>-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer
2023Open Access
Supplementary Table S1 from RhoB Determines Tumor Aggressiveness in a Murine EGFR<sup>L858R</sup>-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer
2023Open Access
Supplementary Figure S1 from RhoB Determines Tumor Aggressiveness in a Murine EGFR<sup>L858R</sup>-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer
2023Open Access
Supplementary Table S1 from RhoB Determines Tumor Aggressiveness in a Murine EGFR<sup>L858R</sup>-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer
2023Open Access
Supplementary Figure S4 from RhoB Determines Tumor Aggressiveness in a Murine EGFR<sup>L858R</sup>-Induced Adenocarcinoma Model and Is a Potential Prognostic Biomarker for Lepidic Lung Cancer
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Julien Mazières(45), Thomas Filleron(23), Oliver Gautschi(21), Isabelle Rouquette(18), Michèle Beau‐Faller(16), Olivier Calvayrac(16), Benjamin Besse(15), Gilles Favre(15), Anne Pradines(14), Emilie Bousquet(14), Valérie Lauwers‐Cancès(13), Isabelle Raymond‐Letron(13), Fabrice Barlési(12), Anne Casanova(12), Gérard Zalcman(10), Alexander Drilon(9), Joachim Diebold(9), Jacques Cadranel(9), Solange Peters(8), Denis Moro‐Sibilot(8)